Overview Flashcards

(27 cards)

1
Q

Main stages in Drug Discovery

A
  1. Early Drug Discovery
  2. Preclinical research
  3. Clinical Drug Development process
  4. Regulatory approval
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Involves finding new medications

A

Early Drug Discovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

helps identify treatments or existing disease through modern testing methods

A

Reverse pharmacology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Steps in Early Discovery

A
  1. Target Identification and validation
  2. HIT Discovery Process
  3. Assay development & Screening
  4. High Throughput screening
  5. HIT to Lead
  6. Lead optimization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

finds a gene or protein (therapeutic agent) that plays a significant role in disease

A

target Identification and validation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

identifies hit compounds that interact effectively with a specific biological target, such as protein or enzyme linked to a disease.

A

HIT discovery process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

show initial promise in modulating the target’s activity and can serve as starting points for further drug development

A

HIT discovery process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Evaluate the effects of the new drug candidate at the cellular, molecular, and biochemical levels

A

Assay Development and Screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drug Discovery method used to rapidly test thousands to millions of chemical compounds for their potential cell receptor associated with a disease

A

High Throughput Screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

stage in drug discovery that involves optimizing initial “hit” compounds.

A

Hit to Lead

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

chemically refined versions of hits with improved therapeutic properties that make them more suitable for further drug development

A

Lead

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

conducts experimental testing using animal efficacy models and ADMET tools, designing the drug candidate

A

Lead Optimization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Molecules that are effective at much smaller dosage levels than standard APIs

A

High Potency Active Pharmaceutical Ingredients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Classified based on toxicity, pharmacological potency, and occupational exposure limits, and used in complex drug development involving more than ten steps

A

High Potency APIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pharmacokinetic process of measuring the ways the new drug affects the body.

A

Absorption, Distribution, Disposition, metabolism, and excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

conducted to determine the efficacy and safety of the drug once a lead compound is found and preclinical phase of drug development begins

A

in vivo research

17
Q

establishes that the basic idea behind a treatment strategy works in a real-world setting

A

Proof of concept

18
Q

a step further, providing initial evidence that the drug not only works as expected but also produces a meaningful therapeutic outcome. More comprehensive studies and focus on mechanism of action.

A

Proof of Principle

19
Q

preclinical research examples are the development of new drugs using mice, rat, and dog models

20
Q

research conducted in the laboratory

21
Q

uses animal cells or tissues from non-living animal

22
Q

newest type of study wherein test systems or biological experiments are performed on a computer or via computer simulation

A

In Silico assays

23
Q

Goal of drug delivery

A

prevent the drug from interacting with healthy tissues while still being effective.

24
Q

Focused on refining the drug’s form and how it is absorbed in the body to ensure maximum therapeutic effect and safety

A

Formulation Optimization and Improving bioavailability

25
Formulation Optimization goals
enhancing stability Improving solubility and dissolution rate controlled release patience convenience and compliance
26
Improving bioavailability
Enhancing solubility Bypassing first-pass metabolism use of permeation enhancers encapsulation techniques
27